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Background: Prevalence of cardiovascular disease (CVD) risk factors have been scarcely studied in Xinjiang,
a multi-ethnic region.
Methods: Multi-ethnic, cross-sectional cardiovascular risk survey study in Xinjiang, including individuals of
Uygur (n = 4695), Han (n = 3717) and Kazakh (n = 3196) ethnicities, aged 35-74 years. Analyses involved
11,608 participants with complete data enrolled between October 2007 and March 2010.
Results: There were differences in age-standardized prevalence of CVD risk factors between the three groups
(all P < 0.001). Hypertension, obesity and smoking rates were higher among Kazakh (54.6%, 24.5%, and 35.8%,
respectively). Dyslipidemia prevalence was higher among Uygur (54.3%), and diabetes prevalence was higher
among Hans (7.1%). Age-standardized prevalence of adverse CVD risk profiles was different across different
ethnicities. Compared with the Han participants, the Uygur and Kazakh had more CVD risk factors (P < 0.001).
Compared with the Han participants, the adjusted odds ratios of 1, 2, and ≥3 risk factors profiles for Kazakh
and Uygur participants were higher (all P < 0.001).
Conclusions: The present study showed the pervasive burden of CVD risk factors in all participant groups in
the Xinjiang region. Three major ethnic groups living in Xinjiang had striking differences in the prevalence of
major CVD risk factors and adverse risk profiles. Ethnic-specific strategies should be developed to prevent CVD
in different ethnic groups, as well as to develop strategies to prevent future development of adverse CVD risk
factors at a younger age.
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Cardiovascular diseases (CVD) account for about half of
non-transmissible diseases deaths worldwide, namely
16.7 million 2002 [1]. In China, with the current shift
toward an elderly population, CVD is an important and
growing public health concern [2], accounting for nearly
40% of deaths in 1994 [3,4]. Furthermore, CVD incidence* Correspondence: myt-xj@163.com
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stated.and mortality in China are projected to increase substan-
tially during the next 20 years [3].
High numbers of CVD risk factors are common in
many developed and developing countries, including
China. These risk factors have emerged as important
characteristics for predicting CVD morbidity and mor-
tality [5]. The main strategy to prevent CVD is to con-
trol these risk factors, thus influencing the probability of
developing CVD.
Recently, several studies have noted the striking differ-
ences in the prevalence of major CVD risk factors and
adverse CVD risk profiles across ethnic groups in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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these ethnic differences have been scarcely studied.
The present study aims to expand the literature on eth-
nic differences in CVD risk factors in China by describing
the prevalence of five major and readily measurable CVD
risk factors (high serum cholesterol or triglycerides and
blood pressure levels, obesity, diabetes, cigarette smoking),
and adverse CVD risk profiles (combinations of CVD risk
factors; i.e., only one, two, or ≥ 3 risk factors) between
three different ethnic groups (Han, Uygur and Kazakh) in
the Xinjiang Uygur Autonomous Region (China), using
data from the Cardiovascular Risk Survey (CRS).
Methods
Ethics statement
This study was approved by the Ethics Committee of the
First Affiliated Hospital of Xinjiang Medical University
and was conducted according to the standards of the
Declaration of Helsinki. Written, informed consent was
obtained from the participants.
Sample design
The CRS study was a multi-ethnic, cross-sectional study
designed to investigate the prevalence of risk factors for
CVD, and to determine their contribution to athero-
sclerosis, coronary artery disease and cerebral infarction
in the Chinese Han, Uygur, and Kazakh populations in
Xinjiang (western China). Details about the sampling
methods and design have been previously published
[8-10]. Briefly, the CRS study used a 4-stage stratified
sampling method to select a representative sample of the
general population in Xinjiang. The research sites in-
cluded seven cities (Urumqi, Kelamayi, Hetian, Zhaosu,
Fukang, Tulufan, and Fuhai). The time period was from
October 2007 to March 2010. The selections made from
sampling units were based on geographic area, sex, and
age groups using household registries. The 4-stage strati-
fied sampling method was as follows: Stage one, accord-
ing to population census data of Xinjiang in 2000, the
area mentioned above were selected based on popula-
tion, ethnicity, geography, economic and cultural devel-
opment level respectively. Stage two, according to the
ethnic aggregation status, one district or county was
randomly selected from the Han, Uygur, Kazak popu-
lation dominated area. Stage three, one community or
town (village) was randomly selected from each district
or county. Stages four, subjects aged above 35 years were
randomly selected from each community or town (village)
as research subjects. The staff conducted surveys in
households and administered questionnaires. The ques-
tionnaires included the demographic, socioeconomic, diet-
ary, and medical history of each participant. In total, the
CRS included 14 618 participants (5757 Hans, 4767
Uyghur, and 4094 Kazakhs).All analyses were restricted to survey participants
without a history of myocardial infarction, stroke, or
congestive heart failure (excluded n = 734), and miss-
ing some values (n = 993) were also excluded from
the analyses, as well as 1283 participants being ≥ 75 years.
Thus, these analyses were based on data from 11608
participants (3717 Han, 4695 Uygur and 3196 Kazakh
people).
Examination methods
Data collection was conducted in examination centers
at the local hospital in the participants’ residential area.
Before examination, participants were asked to fast, to re-
frain from smoking for 12 hours, and to avoid any vigor-
ous physical activity. Height was measured to the nearest
centimeter and body weight to the nearest 0.1 kg. Body
mass index (BMI) was calculated as weight in kilograms
divided by height in meters squared. After a 5-minute rest
period, three seated blood pressure measurements were
obtained using an automatic sphygmomanometer; the
second and third readings were averaged. At the time
of the in-person interview, a 5-mL blood sample was
collected in an EDTA vacutainer tube. Plasma was
separated within 30 min and stored at -80°C immedi-
ately. We measured fasting plasma glucose (FBG), triglycer-
ides (TG), total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein choles-
terol (LDL-C) levels using a Dimension AR/AVL Clinical
Chemistry System (Newark, NJ, USA) in the Clinical
Laboratory Department of the First Affiliated Hospital
of Xinjiang Medical University.
Cardiovascular risk factors
Major CVD risk factors were defined based on current na-
tional guidelines. Dyslipidemia was defined as TG ≥2.26
mmol/l, TC ≥ 6.22 mmol/l, LDL-C ≥ 4.14 mmol/l,
HDL-C < 1.04 mmol/l, or if receiving a lipid-lowering
drug [11]. Hypertension was defined as a systolic blood
pressure (SBP) ≥ 140 mmHg, diastolic blood pressure
(DBP) ≥ 90 mmHg, or if receiving an antihypertensive
drug [12]. Obesity was defined as a BMI ≥30.0 [13]. Dia-
betes was defined as a fasting plasma glucose ≥6.99
mmol/l, or if using a diabetes drug [14]. Smoking was
defined as currently smoking cigarettes.
Statistical analyses
The statistical analysis was conducted using SPSS ver-
sion 16.0 for Windows (SPSS Inc., Chicago, IL, USA).
Age-standardization was performed by the direct method
by using the 2000 Chinese population as the standard
population.
The distribution of clinical characteristics among par-
ticipants stratified by ethnic groups was analyzed using
one-way ANOVA (with the least significant difference
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transformed to normalize their distribution.
The age-standardized prevalence of each CVD risk
factor (dyslipidemia, hypertension, diabetes, smoking,
and obesity) was determined separately for men and
women by ethnic group (Han, Uygur and Kazakh) and
by age group (35-44, 45-54, 55-64, and 65-74 years).
The age-standardized prevalence of adverse CVD risk
profiles (i.e., presence of 0, 1, 2 or ≥3 risk factors) were
determined for the overall study population by ethnic
groups (Han, Uygur and Kazakh), by age groups (35-44,
45-54, 55-64, and 65-74 years) and by gender, separately.
The significance of the differences across subgroups was
compared using the Wald X2test.
The adjusted odds ratios and 95% confidence intervals
(95% CIs) of having one, two or ≥ 3 major CVD risk fac-
tors vs. no CVD risk factor were determined using mul-
tivariable logistic regression models that included ethnic
group, age group and gender.
Results
Clinical characteristics
Table 1 presents the clinical characteristics of the partic-
ipants. BMI, DBP, and TC were significantly higher in
the Kazakh and Uygur groups compared with the Han
group (all P < 0.001). FBG levels were significantly lowerTable 1 Characteristics of all participants and by ethnic
groups in Xinjiang
Total Han Uygur Kazakh
N=11,608 N=3,717 N=4,695 N=3,196
Age (y) 51.1±10.5 51.3±10.3 51.9±11.0 49.7±10.0
Gender (female, %) 6,337 (54.6) 2,179 (58.6) 2,493 (53.1) 1,665 (52.1)
BMI (kg/m2)* 25.9±4.2 25.1±3.5 26.0±4.4 26.8±4.8
SBP (mmHg)& 134.9±22.2 132.2±21.0 132.4±19.7 141.9±25.2
DBP (mmHg)* 85.2±16.8 81.0±14.7 85.4±15.5 89.8±19.6
FBG (mmol/L)# 5.15±1.69 5.32±1.80 4.94±1.65 5.16±1.55
TG (mmol/L)$ 1.27±0.82 1.39±0.84 1.39±0.78 1.01±0.37
TC (mmol/L)* 4.64±1.12 4.39±1.09 4.71±1.08 4.82±1.17
HDL-C (mmol/L)& 1.26±0.46 1.26±0.48 1.25±0.46 1.29±0.43
LDL-C (mmol/L)** 2.88±0.92 2.86±0.92 2.87±0.92 2.90±0.93
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass
index, TC serum total cholesterol, TG triglyceride, LDL-C low-density lipoprotein
cholesterol, HDL-C high-density lipoprotein cholesterol, FBG fasting
blood glucose.
The differences between ethnic groups were performed by F-test or by χ2test.
*Significantly higher for Kazakh and Uygur than Han, there were differences
between the three groups. (All P < 0.001).
&Significantly higher for Kazakh than Uygur and Han (P < 0.05), but there was
no difference between Uygur and Han.
#Significantly higher for Han than Uygur and Kazakh, there were differences
between the three groups. (All P < 0.001).
$Levels were log-transformed to normalize their distribution, and significantly
higher for Uygur and Han than Kazakh (P < 0.001), but there was no difference
between Uygur and Han.
**No difference between the three groups (P > 0.05).in the Kazakh and Uygur groups compared with the Han
group (P < 0.001). SBP and HDL-C levels were highest in
the Kazakh (P < 0.05), which had no difference in the Han
and Uygur groups. TG levels were log-transformed to
normalize their distribution, and significantly higher for
Uygur and Han than Kazakh (P < 0.001), but there was no
difference between Uygur and Han. And no difference
was observed in LDL-C levels between the three groups.
Prevalence of CVD risk factors in Xinjiang
In the Xinjiang population aged 35-74 years, the age-
standardized prevalence of hypertension, diabetes, obesity,
dyslipidemia and smoking were 44.2%, 5.5%, 15.6%, 51.7%
and 28.6%, respectively. In Han participants, prevalence of
these diseases was 36%, 7.1%, 8.1%, 53.3% and 19.3%,
respectively. In Uygur participants, prevalence of these
diseases was 43.7%, 5.4%, 17.6%, 54.3% and 31.1%. Finally,
in Kazakh participants, prevalence of these diseases was
54.6%, 3.4%, 24.5%, 45.9% and 35.8% (Table 2).
The age-standardized prevalence of hypertension, dia-
betes, dyslipidemia and smoking was higher in men than
in women (all P < 0.001). However, in Uygur partici-
pants, the prevalence of obesity was higher in women
than in men (P < 0.001) (Table 2).
Hypertension and diabetes prevalence increased with
age, while smoking decreased with age among all partici-
pants (all P < 0.001). Among Han and Uygur participants,
hypertension prevalence increased for the entire age range
(all P < 0.001). Among Kazakh participants, hyperten-
sion and dyslipidemia prevalence increased with age
(all P <0.001) (Table 2).
The age-standardized prevalence of hypertension,
obesity and smoking was significantly higher in Uygur
and Kazakh than compared with Han participants (all
P < 0.001). Diabetes prevalence was higher in Han par-
ticipants, and lower in Kazakh participants. Dyslipidemia
prevalence was higher in Uygur participants, and lower
in Kazakh participants (Table 2).
Prevalence of adverse CVD risk profiles in Xinjiang
Overall, 17.5% of men had only one major risk factor,
while 29.5% and 48.8% had two or three or more risk
factors, respectively. Among women, 30.2% had only one
risk factor, while 33.3% and 24.8% had two or three or
more risk factors, respectively (Figure 1).
Overall, 13.3% of participants aged 35-44 years did
not have any of the investigated risk factors, while
25.9% had three or more risk factors. By contrast,
4.3% of participants aged 65-74 did not have any of
the investigated risk factors, while 44.8% had three or
more risk factors. The number of risk factors in-
creased with age (Figure 1).
Overall, 9.6%, 27.4%, 28.8% and 28.4% of Han, 9.2%,
25.5%, 32.1% and 36.5% of Uygur, and 5.5%, 19.4%, 34.6%
Table 2 Age- and gender-standardized prevalence of CVD risk factors in Xinjiang by ethnic groups
Ethnic groups (n) Hypertension (%) Diabetes (%) Obesity (%) Dyslipidemia (%) Smoking (%)
Total
Overall(11608) 44.2 5.5 15.6 51.7 28.6
35-44y(3999) 28.1 3.1 12.7 48.0 30.6
45-54y(3339) 43.8 3.2 17.3 52.9 29.7
55-64y(2559) 56.2 6.6 18.6 54.4 26.1
65-74y(1711) 65.0 8.4 14.7 53.5 25.6
Men(5271) 46.5 6.6 15.3 54.5 56.3
Women(6337) 42.3 4.6 15.9 49.3 5.6
Han
Overall(3717) 36.0 7.1 8.1 53.3 19.3
35-44y(1158) 19.1 3.8 5.8 49.3 18.1
45-54y(1109) 37.5 8.4 6.5 53.1 20.1
55-64y(952) 46.0 8.1 11.7 58.4 20.1
65-74y(498) 52.6 10.4 10.4 53.6 19.1
Men(1583) 35.1 8.4 8.9 54.4 45.4
Women(2179) 36.6 6.0 7.3 52.6 1.0
Uygur
Overall(4695) 43.7 5.4 17.6 54.3 31.1
35-44y(1643) 29.2 2.8 16.2 51.6 32.9
45-54y(1228) 37.7 5.5 20.0 57.1 35.2
55-64y(948) 55.8 7.6 17.5 54.5 26.5
65-74y(876) 66.1 7.2 15.3 55.1 26.9
Men(2202) 46.5 6.0 14.8 58.8 63.6
Women(2493) 41.2 5.0 19.6 50.3 2.4
Kazakh
Overall(3196) 54.6 3.4 24.5 45.9 35.8
35-44y(1198) 35.1 2.5 18.8 42.0 39.6
45-54y(1002) 58.2 4.2 27.3 47.6 33.7
55-64y(659) 71.3 3.2 30.2 48.6 34.1
65-74y(337) 80.7 5.0 24.9 49.3 31.8
Men(1531) 58.1 4.8 25.1 48.3 56.6
Women(1665) 51.4 2.2 23.8 43.6 16.6
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma
glucose ≥ 6.99 mmol/L and/or current diabetes drug use. Obesity was defined as BMI ≥ 30 kg/m2. Dyslipidemia was defined as TG ≥ 2.26 mmol/L, TC ≥ 6.22 mmol/L,
HDL-C < 1.04 mmol/L, LDL-C ≥ 4.14 mmol/L, and/or current lipid-lowering drug use.
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three or more risk factors, respectively. In summary, com-
pared with the Han participants, the Uygur and Kazakh
had more risk factors (Figure 1).
Compared with the Han participants, the adjusted
odds ratio of having one, two, or three or more CVD
risk factors for the Uygur participants were 1.16, 1.29
and 1.55; and were 1.72, 2.75 and 4.03, respectively, for
the Kazakh participants. The adjusted odds ratio of
having CVD risk factors vs. none increased progressively
with increasing age. The adjusted odds ratios for havingone, two, or three or more CVD risk factors for subjects
aged 65-74 years compared with patients aged 35-44
were 2.23, 4.27 and 4.82, respectively. In addition, males
were more likely to have one, two, or three or more
CVD risk factors compared with females(all P < 0.001)
(Table 3).
Discussion
The present study provides several insights about CVD
risk factors among Chinese Han, Uygur, and Kazakh par-
ticipants in Xinjiang. The results of the present study
Figure 1 Age-standardized prevalence of adverse CVD risk
profiles among Xinjiang participants stratified by gender
groups (top), age groups (middle), and ethnic groups (bottom).
Table 3 Adjusted* odds ratios (95% CI) of having one, two
or three or more vs. none CVD risk factors according to
gender, age, and ethnic groups
1 risk factor 2 risk factors ≥3 risk factors
Ethnic groups
Han 1.00 (ref) 1.00 (ref) 1.00 (ref)
Uygur 1.16 (1.03-1.29) 1.29 (1.14-1.46) 1.55 (1.32-1.83)
Kazakh 1.72 (1.50-1.97) 2.75 (2.37-3.18) 4.03 (3.37-4.82)
Age groups
35-44y 1.00 (ref) 1.00 (ref) 1.00 (ref)
45-54y 1.30 (1.15-1.47) 2.00 (1.75-2.29) 2.26 (1.91-2.69)
55-64y 1.90 (1.65-2.19) 3.50 (3.00-4.08) 3.96 (3.28-4.79)
65-74y 2.23 (1.87-2.65) 4.27 (3.56-5.13) 4.82 (3.87-6.00)
Male gender 1.96 (1.76-2.18) 3.54 (3.15-3.97) 6.55 (5.68-7.56)
*All variables (age, gender and ethnic groups) were included in the same
models; thus the odds ratios for age groups were adjusted for gender and
ethnic group; the odds ratios for gender were adjusted for age groups and
ethnic group; and the odds ratios for ethnic grouping were adjusted for age
groups and gender.
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prevalence of hypertension, diabetes, obesity, dyslipid-
emia and smoking was 36%, 7.1%, 8.1%, 53.3% and
19.3%, respectively. In Uygur participants, prevalence of
these diseases was 43.7%, 5.4%, 17.6%, 54.3% and 31.1%.
In Kazakh participants, prevalence of these diseases was
54.6%, 3.4%, 24.5%, 45.9% and 35.8%. Furthermore, 9.6%,
27.4%, 28.8% and 28.4% of Han, 9.2%, 25.5%, 32.1% and
36.5% of Uygur, and 5.5%, 19.4%, 34.6% and 43.0% of
Kazakh participants had none, one, two or three or more
risk factors, respectively. Finally, compared with the Han
participants, the adjusted odds ratios of 1, 2, and ≥3 risk
factors profiles for Kazakh and Uygur participants were
higher.
Several studies have noted the striking differences across
ethnic groups in the prevalence of CVD risk factors
in the world [15-17]. In this study, we observed thatthe prevalence of individual major CVD risk factors
varied markedly across these three different ethnic
groups. Hypertension, obesity and smoking rates were
higher among Kazakh. Dyslipidemia prevalence was
higher among Uygur, and diabetes prevalence was higher
among Hans. Moreover, age-standardized prevalence of
adverse CVD risk profiles was different across different
ethnic groups. Compared with the Han participants,
Uygur and Kazakh participants were more likely to have
multiple CVD risk factors, reflecting the fact that all of the
investigated CVD risk factors except diabetes were more
frequent in Uygur or Kazakh participants.
Ethnicity is a social construct, a concept that inter-
twines biological, sociocultural, psychological and behav-
ioral components. All ethnic groups can share a range of
phenotypic characteristics due to the shared ancestry;
the term ethnicity is typically used to highlight cultural
and social characteristics such as language, ancestry, reli-
gious traditions, dietary preferences and history. The study
of Latinos showed [18] that age-standardized prevalence of
CVD risk factors varied by Hispanic/Latino background,
prevalence of adverse CVD risk profiles was higher among
participants with Puerto Rican background, which had
lower socioeconomic status, and higher levels of accultur-
ation. Another study in India [19] found marked differ-
ences in conventional risk factors between the Meitei and
the Aggarwal, since the genetic and cultural backgrounds
are different for both groups.
The mechanisms underlying the striking differences
across ethnic groups in the prevalence of hypertension,
diabetes, dyslipidemia, obesity and smoking are not clear.
In this study, it is believed that different environmental
exposures among Chinese Han, Uygur and Kazakh ethnic
groups may play an important role. Beside the Han
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Kazakh participants is relatively isolated and fixed.
Most Kazakh people live as animal raisers and reside
in the villages and forests north of Xinjiang, which
are cold and semiarid, while most Uygur people live
as farmers in the plains south of Xinjiang, which are
hot and arid. Moreover, Chinese Uygur and Kazakh share
similar dietary habits, characterized by drinking strong
wine, eating more animal fat, a higher salt intake and con-
suming less grain, fresh vegetables, beans, bean products,
and unsaturated fatty acids [20]. In addition to different
environmental exposures among Chinese Han, Uygur and
Kazakh ethnic groups, differences in genetic back-
grounds and gene-environment interactions could also
be important factors underlying the different preva-
lence of hypertension [21-24] and diabetes [25]. Fur-
ther studies between these adverse CVD risk profiles
and ethnic-specific genetic susceptibility are needed to
clarify this observation.
Several studies in the United States have investigated
the impact of adverse risk profiles on CVD incidence,
mortality, and quality of life [26-30]. In these studies,
CVD incidence and all-cause mortality increased pro-
gressively and substantially in the presence of more risk
factors. For example, data from the First NHANES
Epidemiologic Follow-up Study showed that the age-,
race-, sex-, and education-adjusted relative risks of CVD
during the 21-year follow-up in adults with one, two,
three, four or five risk factors were 1.6,2.2, 3.1, and 5.0,
respectively, vs. participants without any risk factor [30].
In longitudinal studies, the presence of CVD risk factors
at baseline has been associated with a diminished quality
of life [26]. These programs to enhance efforts aimed at
prevention, detection, and treatment of dyslipidemia,
hypertension, diabetes, smoking, and obesity may greatly
reduce the future burden of CVD.
The striking differences across ethnic groups with
regard to the prevalence of CVD risk factors and
adverse CVD risk profiles emphasize the need for the
development of ethnic-specific and cost-effective CVD
prevention programs and health services to reduce the
prevalence of these risk factors, as well as CVD morbidity
and mortality in the Chinese Han, Uygur and Kazakh par-
ticipants in Xinjiang. In addition, future public health
interventions need to take into account the special needs
of people living in Xinjiang. Effective interventions such as
smoking cessation, improved diet (reduction of salt and
fat), and increased physical activity can safely and effect-
ively lower the risk of CVD [31]. A multidisciplinary and
targeted approach aiming at prevention, detection and
treatment of hypertension, dyslipidemia, diabetes, obesity
and smoking could substantially reduce the prevalence of
adverse CVD risk profiles, as well as CVD morbidity and
mortality.Participants with a history of myocardial infarction,
stroke, or congestive heart failure were excluded from
our analyses in order to focus on the burden of CVD
risk factors among patients without CVD. Nonetheless,
results were markedly consistent when participants with
existing CVD complications were included in the ana-
lyses. We chose not to include physical inactivity as a
CVD risk factor in the current analyses because it is
causally involved in the development of all CVD risk
factors studied, except cigarette smoking. Inclusion of
physical inactivity as a risk factor would have artificially
inflated the prevalence of CVD risk factor profiles. The
findings of the present study are limited to self-reported
information. However, the data were age-standardized
to the Chinese population in 2000 to allow for compari-
sons with observations from national surveys, and proto-
cols used were similar to those of other epidemiological
studies.
In conclusion, the present study demonstrated the
pervasive burden of CVD risk factors in all participant
groups in Xinjiang and identified specific ethnic groups
at particularly high risk of CVD. These data may in-
crease the need to implement interventions to lower the
burden of CVD risk factors among Xinjiang people over-
all. Ethnic-specific strategies should be developed to pre-
vent CVD in different ethnic groups, as well as strategies
to prevent future development of adverse CVD risk
factors starting at the youngest ages.
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